002793 Luoxin Pharmaceuticals Group Stock
- 4.27
- -0.08-1.84%
About Luoxin Pharmaceuticals Group Stock Company
The company is a large pharmaceutical enterprise group integrating drug research and development, production, trade and medical and health services. The company's main business is research and development, production and sales of pharmaceutical products, focusing on superior fields such as digestion, respiration, and anti-tumor. Main products: Tigolacin tablets, omeprazole enteric capsules, omeprazole sodium for injection, glutathione for injection, lansoprazole for injection, rabeprazole sodium for injection, ambroxol hydrochloride spray, ambroxol hydrochloride injection, roxithromycin ambroxol tablets, ambroxol hydrochloride tablets, erdostane dispersible tablets, clindamycin phosphate for injections, meropenem for injections, ceffuroxime sodium for injections, cefazol for injections Shi San, Yuanhu Pain Relief Tablets, Xiaojianzhong Compound, Gantai Granules, Hawthorn Granules, Abdominal Pain Solution; Blood Relieving Tablets, Shengmai Drink, Yupingfeng Oral Liquid , Brain Relieving Oral Liquid, Shuangdan Oral Liquid; Pediatric Cough and Panning Granules, etc. Company honors: The company has been on the “Top 100 Chinese Pharmaceutical Companies List” for 17 consecutive years, the “Most Influential Chinese Pharmaceutical Industry List” for 10 consecutive years, won the “China Pharmaceutical Research and Development Product Line Best Industrial Enterprise” award for 13 consecutive years, and the “Top 20 Innovative Pharmaceutical Enterprises in China” for 5 consecutive years. During the reporting period, it won “China Pharmaceutical Independent Innovation Pioneer Enterprise”, “China Pharmaceutical Industry Law-abiding and Honest Enterprise”, “Shandong Province's 2023 First Batch of Innovative Small and Medium Enterprises”, “Shandong Province's 2023 Specialized and Special New Small and Medium Enterprises”, Zhejiang Famous Brand Products, Advanced Unit for “Honest and Law-abiding Enterprise” activities, 2014 Top Ten Industrial Enterprises, Contract-abiding and Credit-abiding AA, etc.
Company Profile
Company Executives
- Name
- Position
- Salary
- zhenteng liu
- Chairman, Directors, General Manager, Nomination Committee Members, Chairman of the Strategy Committee, Member of the Remuneration and Assessment Committee
- 1.88M
- zhenfei liu
- Directors, Audit Committee Member, Strategy Committee Member
- 1.93M
- meng li
- Directors, Deputy General Manager, Strategy Committee Member
- 3.37M
- zhiang wu
- Independent Directors, Chairman of the Nomination Committee, Member of the Remuneration and Assessment Committee
- 80.00K
- xia xu
- Independent Directors, Nomination Committee Members, Chairman of the Audit Committee
- 80.00K
- yunpei guo
- Independent Directors, Audit Committee Member, Chairman of the Remuneration and Assessment Committee
- 80.00K
- fengsheng han
- Board Secretary
- 566.40K
- jianhua wang
- Securities Affairs Representative
- --
- liangwei song
- Chairman of the Supervisory Board, Employee Supervisors
- 963.50K
- fang xia
- Auditors
- 18.20K
- xiaotong zhu
- Deputy General Manager
- 2.54M
- xian chen
- Head of Finance
- 2.45M
- anmin tang
- Head of an Internal Audit Agency
- --
- jie lv
- Employee Supervisors
- --
- lili song
- Employee Supervisors
- --
Analysis
Price Target
No Data
No Data